229 related articles for article (PubMed ID: 30668434)
1. Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells.
Fratantonio D; Molonia MS; Bashllari R; Muscarà C; Ferlazzo G; Costa G; Saija A; Cimino F; Speciale A
Phytomedicine; 2019 Mar; 55():23-30. PubMed ID: 30668434
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
Tianqin G; Chunlei C; Jingjing W
Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785
[TBL] [Abstract][Full Text] [Related]
3. Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.
Allegra A; Speciale A; Molonia MS; Guglielmo L; Musolino C; Ferlazzo G; Costa G; Saija A; Cimino F
Toxicol In Vitro; 2018 Mar; 47():186-194. PubMed ID: 29223572
[TBL] [Abstract][Full Text] [Related]
4. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
Ruttala HB; Ko YT
Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
[TBL] [Abstract][Full Text] [Related]
5. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
6. Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.
Zhou C; Cheng H; Qin W; Zhang Y; Xiong H; Yang J; Huang H; Wang Y; Chen XZ; Tang J
Oncotarget; 2017 Apr; 8(17):27915-27928. PubMed ID: 28427190
[TBL] [Abstract][Full Text] [Related]
7. Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings.
Li D; Yang K; Li JS; Ke XY; Duan Y; Du R; Song P; Yu KF; Ren W; Huang D; Li XH; Hu X; Zhang X; Zhang Q
Int J Nanomedicine; 2012; 7():6105-14. PubMed ID: 23269869
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat.
Ke XY; Zhao BJ; Zhao X; Wang Y; Huang Y; Chen XM; Zhao BX; Zhao SS; Zhang X; Zhang Q
Biomaterials; 2010 Aug; 31(22):5855-64. PubMed ID: 20430438
[TBL] [Abstract][Full Text] [Related]
9. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma.
Liu E; Wu J; Cao W; Zhang J; Liu W; Jiang X; Zhang X
J Neurooncol; 2007 Dec; 85(3):263-70. PubMed ID: 17594054
[TBL] [Abstract][Full Text] [Related]
10. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
Wang L; Ye X; Cai X; Su J; Ma R; Yin X; Zhou X; Li H; Wang Z
Oncotarget; 2015 Jul; 6(20):18027-37. PubMed ID: 26046466
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
Calaf GM; Ponce-Cusi R; Carrión F
Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
[TBL] [Abstract][Full Text] [Related]
13. Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells.
Hacioglu C; Kar F; Kacar S; Sahinturk V; Kanbak G
Med Oncol; 2021 Feb; 38(3):31. PubMed ID: 33599853
[TBL] [Abstract][Full Text] [Related]
14. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
15. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
[TBL] [Abstract][Full Text] [Related]
16. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects.
Ashrafizadeh M; Zarrabi A; Hashemi F; Moghadam ER; Hashemi F; Entezari M; Hushmandi K; Mohammadinejad R; Najafi M
Life Sci; 2020 Sep; 256():117984. PubMed ID: 32593707
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
18. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
19. Combined Delivery and Anti-Cancer Activity of Paclitaxel and Curcumin Using Polymeric Micelles.
Gao X; Wang B; Wu Q; Wei X; Zheng F; Men K; Shi H; Huang N; Wei Y; Gong C
J Biomed Nanotechnol; 2015 Apr; 11(4):578-89. PubMed ID: 26310065
[TBL] [Abstract][Full Text] [Related]
20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
